Global Anti-Emetic Drug Market Research Report 2021

Publisher Name :
Date: 23-Mar-2021
No. of pages: 118
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Oral

- Injection

- Others

Segment by Application

- Hospital

- Clinic

- Home Care

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Merck

- Novartis

- Glenmark Pharmaceuticals

- F. Hoffmann-La Roche

- Heron Therapeutics

- Kyowa Kirin

- Aurobindo Pharma

- Mylan

- Hikma

- Akorn

- Dr. Reddy's Laboratories

- Cipla

- Fresenius Kabi

- Wockhardt

- Sun Pharmaceutical Industries

- Teva Pharmaceutical

- Pfizer

Global Anti-Emetic Drug Market Research Report 2021

Table of Contents
1 Anti-Emetic Drug Market Overview
1.1 Product Overview and Scope of Anti-Emetic Drug
1.2 Anti-Emetic Drug Segment by Type
1.2.1 Global Anti-Emetic Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Anti-Emetic Drug Segment by Application
1.3.1 Anti-Emetic Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Global Anti-Emetic Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Emetic Drug Revenue 2016-2027
1.4.2 Global Anti-Emetic Drug Sales 2016-2027
1.4.3 Anti-Emetic Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Anti-Emetic Drug Market Competition by Manufacturers
2.1 Global Anti-Emetic Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Emetic Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Emetic Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Emetic Drug Manufacturing Sites, Area Served, Product Type
2.5 Anti-Emetic Drug Market Competitive Situation and Trends
2.5.1 Anti-Emetic Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Emetic Drug Players Market Share by Revenue
2.5.3 Global Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Emetic Drug Retrospective Market Scenario by Region
3.1 Global Anti-Emetic Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-Emetic Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-Emetic Drug Market Facts & Figures by Country
3.3.1 North America Anti-Emetic Drug Sales by Country
3.3.2 North America Anti-Emetic Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Emetic Drug Market Facts & Figures by Country
3.4.1 Europe Anti-Emetic Drug Sales by Country
3.4.2 Europe Anti-Emetic Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Emetic Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Emetic Drug Sales by Region
3.5.2 Asia Pacific Anti-Emetic Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Emetic Drug Market Facts & Figures by Country
3.6.1 Latin America Anti-Emetic Drug Sales by Country
3.6.2 Latin America Anti-Emetic Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Emetic Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Emetic Drug Sales by Country
3.7.2 Middle East and Africa Anti-Emetic Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-Emetic Drug Historic Market Analysis by Type
4.1 Global Anti-Emetic Drug Sales Market Share by Type (2016-2021)
4.2 Global Anti-Emetic Drug Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Emetic Drug Price by Type (2016-2021)
5 Global Anti-Emetic Drug Historic Market Analysis by Application
5.1 Global Anti-Emetic Drug Sales Market Share by Application (2016-2021)
5.2 Global Anti-Emetic Drug Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Emetic Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Corporation Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Glenmark Pharmaceuticals Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 F. Hoffmann-La Roche Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Heron Therapeutics
6.5.1 Heron Therapeutics Corporation Information
6.5.2 Heron Therapeutics Description and Business Overview
6.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Heron Therapeutics Product Portfolio
6.5.5 Heron Therapeutics Recent Developments/Updates
6.6 Kyowa Kirin
6.6.1 Kyowa Kirin Corporation Information
6.6.2 Kyowa Kirin Description and Business Overview
6.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Kyowa Kirin Product Portfolio
6.6.5 Kyowa Kirin Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aurobindo Pharma Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Hikma
6.9.1 Hikma Corporation Information
6.9.2 Hikma Description and Business Overview
6.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hikma Product Portfolio
6.9.5 Hikma Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Akorn Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Anti-Emetic Drug Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Dr. Reddy's Laboratories Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Anti-Emetic Drug Description and Business Overview
6.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Cipla Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Fresenius Kabi
6.13.1 Fresenius Kabi Corporation Information
6.13.2 Fresenius Kabi Anti-Emetic Drug Description and Business Overview
6.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Fresenius Kabi Product Portfolio
6.13.5 Fresenius Kabi Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Anti-Emetic Drug Description and Business Overview
6.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Wockhardt Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Sun Pharmaceutical Industries
6.15.1 Sun Pharmaceutical Industries Corporation Information
6.15.2 Sun Pharmaceutical Industries Anti-Emetic Drug Description and Business Overview
6.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sun Pharmaceutical Industries Product Portfolio
6.15.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.16 Teva Pharmaceutical
6.16.1 Teva Pharmaceutical Corporation Information
6.16.2 Teva Pharmaceutical Anti-Emetic Drug Description and Business Overview
6.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Teva Pharmaceutical Product Portfolio
6.16.5 Teva Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Anti-Emetic Drug Description and Business Overview
6.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Pfizer Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
7 Anti-Emetic Drug Manufacturing Cost Analysis
7.1 Anti-Emetic Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Emetic Drug
7.4 Anti-Emetic Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Emetic Drug Distributors List
8.3 Anti-Emetic Drug Customers
9 Anti-Emetic Drug Market Dynamics
9.1 Anti-Emetic Drug Industry Trends
9.2 Anti-Emetic Drug Growth Drivers
9.3 Anti-Emetic Drug Market Challenges
9.4 Anti-Emetic Drug Market Restraints
10 Global Market Forecast
10.1 Anti-Emetic Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Emetic Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Emetic Drug by Type (2022-2027)
10.2 Anti-Emetic Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Emetic Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Emetic Drug by Application (2022-2027)
10.3 Anti-Emetic Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Emetic Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Emetic Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Emetic Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Emetic Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anti-Emetic Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Emetic Drug Covered in This Study
Table 5. Global Anti-Emetic Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Emetic Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-Emetic Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Emetic Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Emetic Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Emetic Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Emetic Drug Product Type
Table 12. Global Anti-Emetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Emetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Emetic Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Emetic Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Anti-Emetic Drug Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Emetic Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Emetic Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Anti-Emetic Drug Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Emetic Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Emetic Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anti-Emetic Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Emetic Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Emetic Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anti-Emetic Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Emetic Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Emetic Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Emetic Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anti-Emetic Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Emetic Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Emetic Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anti-Emetic Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Emetic Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Emetic Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Emetic Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Anti-Emetic Drug Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Emetic Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Emetic Drug Revenue Share by Type (2016-2021)
Table 42. Global Anti-Emetic Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Anti-Emetic Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Anti-Emetic Drug Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Emetic Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Emetic Drug Revenue Share by Application (2016-2021)
Table 47. Global Anti-Emetic Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merck Anti-Emetic Drug Product
Table 52. Merck Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Novartis Anti-Emetic Drug Product
Table 57. Novartis Recent Developments/Updates
Table 58. Glenmark Pharmaceuticals Corporation Information
Table 59. Glenmark Pharmaceuticals Description and Business Overview
Table 60. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Glenmark Pharmaceuticals Anti-Emetic Drug Product
Table 62. Glenmark Pharmaceuticals Recent Developments/Updates
Table 63. F. Hoffmann-La Roche Corporation Information
Table 64. F. Hoffmann-La Roche Description and Business Overview
Table 65. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. F. Hoffmann-La Roche Anti-Emetic Drug Product
Table 67. F. Hoffmann-La Roche Recent Developments/Updates
Table 68. Heron Therapeutics Corporation Information
Table 69. Heron Therapeutics Description and Business Overview
Table 70. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Heron Therapeutics Anti-Emetic Drug Product
Table 72. Heron Therapeutics Recent Developments/Updates
Table 73. Kyowa Kirin Corporation Information
Table 74. Kyowa Kirin Description and Business Overview
Table 75. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Kyowa Kirin Anti-Emetic Drug Product
Table 77. Kyowa Kirin Recent Developments/Updates
Table 78. Aurobindo Pharma Corporation Information
Table 79. Aurobindo Pharma Description and Business Overview
Table 80. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Aurobindo Pharma Anti-Emetic Drug Product
Table 82. Aurobindo Pharma Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Mylan Anti-Emetic Drug Product
Table 87. Mylan Recent Developments/Updates
Table 88. Hikma Corporation Information
Table 89. Hikma Description and Business Overview
Table 90. Hikma Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Hikma Anti-Emetic Drug Product
Table 92. Hikma Recent Developments/Updates
Table 93. Akorn Corporation Information
Table 94. Akorn Description and Business Overview
Table 95. Akorn Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Akorn Anti-Emetic Drug Product
Table 97. Akorn Recent Developments/Updates
Table 98. Dr. Reddy's Laboratories Corporation Information
Table 99. Dr. Reddy's Laboratories Description and Business Overview
Table 100. Dr. Reddy's Laboratories Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Dr. Reddy's Laboratories Anti-Emetic Drug Product
Table 102. Dr. Reddy's Laboratories Recent Developments/Updates
Table 103. Cipla Corporation Information
Table 104. Cipla Description and Business Overview
Table 105. Cipla Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Cipla Anti-Emetic Drug Product
Table 107. Cipla Recent Developments/Updates
Table 108. Fresenius Kabi Corporation Information
Table 109. Fresenius Kabi Description and Business Overview
Table 110. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Fresenius Kabi Anti-Emetic Drug Product
Table 112. Fresenius Kabi Recent Developments/Updates
Table 113. Wockhardt Corporation Information
Table 114. Wockhardt Description and Business Overview
Table 115. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Wockhardt Anti-Emetic Drug Product
Table 117. Wockhardt Recent Developments/Updates
Table 118. Sun Pharmaceutical Industries Corporation Information
Table 119. Sun Pharmaceutical Industries Description and Business Overview
Table 120. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Sun Pharmaceutical Industries Anti-Emetic Drug Product
Table 122. Sun Pharmaceutical Industries Recent Developments/Updates
Table 123. Teva Pharmaceutical Corporation Information
Table 124. Teva Pharmaceutical Description and Business Overview
Table 125. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Teva Pharmaceutical Anti-Emetic Drug Product
Table 127. Teva Pharmaceutical Recent Developments/Updates
Table 128. Pfizer Corporation Information
Table 129. Pfizer Description and Business Overview
Table 130. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Pfizer Anti-Emetic Drug Product
Table 132. Pfizer Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Anti-Emetic Drug Distributors List
Table 136. Anti-Emetic Drug Customers List
Table 137. Anti-Emetic Drug Market Trends
Table 138. Anti-Emetic Drug Growth Drivers
Table 139. Anti-Emetic Drug Market Restraints
Table 140. Global Anti-Emetic Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 141. Global Anti-Emetic Drug Sales Market Share Forecast by Type (2022-2027)
Table 142. Global Anti-Emetic Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 143. Global Anti-Emetic Drug Revenue Market Share Forecast by Type (2022-2027)
Table 144. Global Anti-Emetic Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 145. Global Anti-Emetic Drug Sales Market Share Forecast by Application (2022-2027)
Table 146. Global Anti-Emetic Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 147. Global Anti-Emetic Drug Revenue Market Share Forecast by Application (2022-2027)
Table 148. Global Anti-Emetic Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 149. Global Anti-Emetic Drug Sales Market Share Forecast by Region (2022-2027)
Table 150. Global Anti-Emetic Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 151. Global Anti-Emetic Drug Revenue Market Share Forecast by Region (2022-2027)
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Emetic Drug
Figure 2. Global Anti-Emetic Drug Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Emetic Drug Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Home Care
Figure 10. Others
Figure 11. Global Anti-Emetic Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-Emetic Drug Market Size 2016-2027 (US$ Million)
Figure 13. Global Anti-Emetic Drug Sales 2016-2027 (K Units)
Figure 14. Global Anti-Emetic Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Anti-Emetic Drug Sales Share by Manufacturers in 2020
Figure 16. Global Anti-Emetic Drug Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Anti-Emetic Drug Players: Market Share by Revenue in 2020
Figure 18. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Anti-Emetic Drug Sales Market Share by Region (2016-2021)
Figure 20. Global Anti-Emetic Drug Sales Market Share by Region in 2020
Figure 21. Global Anti-Emetic Drug Revenue Market Share by Region (2016-2021)
Figure 22. Global Anti-Emetic Drug Revenue Market Share by Region in 2020
Figure 23. U.S. Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Anti-Emetic Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Anti-Emetic Drug by Type (2016-2021)
Figure 48. Sales Market Share of Anti-Emetic Drug by Application (2016-2021)
Figure 49. Sales Market Share of Anti-Emetic Drug by Application in 2020
Figure 50. Revenue Share of Anti-Emetic Drug by Application (2016-2021)
Figure 51. Revenue Share of Anti-Emetic Drug by Application in 2020
Figure 52. Manufacturing Cost Structure of Anti-Emetic Drug
Figure 53. Manufacturing Process Analysis of Anti-Emetic Drug
Figure 54. Anti-Emetic Drug Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs